Found 12 matching trials
The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects PHASE3 The primary efficacy index of this study is to compare the OS of the two gr...
Show More Location
First Affiliated Hospital Bengbu Medical College
Learn More & Join Trial
Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission PHASE2 RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of...
Show More Location
Memorial Sloan - Kettering Cancer Center
Learn More & Join Trial
Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery PHASE1 RATIONALE: Sorafenib tosylate may stop the growth of tumor cells by blockin...
Show More Location
Mayo Clinic Scottsdale
Learn More & Join Trial
QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine PHASE1 This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Show More Location
Chan Soon-Shiong Institute for Medicine
Learn More & Join Trial
A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC) PHASE3 This is a randomized, controlled, open-label, multicenter study to evaluate...
Show More Status
Active Not Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Learn More & Join Trial
AflacLL1901 (CHOA-AML) PHASE2 The investigators propose to study an Aflac-AML chemotherapy backbone prosp...
Show More Location
Egleston Hospital
Learn More & Join Trial
External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer PHASE1 RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. D...
Show More Location
Szent Laszlo Korhaz
Learn More & Join Trial
Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma PHASE1 Mapatumumab is a fully human, agonist monoclonal antibody that activates th...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal PHASE2 The purpose of this study is to see if preoperative administration of Soraf...
Show More Location
Princess Margaret Hospital, University Health Network
Learn More & Join Trial
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma PHASE3 This study will evaluate the safety and efficacy of Dovitinib versus sorafe...
Show More Location
Highlands Oncology Group Dept of Highlands Oncology Grp
Learn More & Join Trial